-
Study aim
-
Determining the effectiveness and side effects of intrauterine insemination catheter with mandrel, a product of Slamtyar Hakim engineering company, in infertile couples
-
Design
-
A randomized Controlled Trial, with parallel groups, 60 patients , and without blinding. The patients randomly assigned to two groups using a random permutation block design
-
Settings and conduct
-
This is a concurrent parallel randomized controlled trial. This study will be performed in Shahid Beheshti Hospital (Isfahan) and without blinding. A total of 60 infertile couples will included in the study and randomly assigned into 2 groups of intervention and control. After intrauterine insemination, the first pregnancy test will be done about 2 weeks later to determine the status of chemical pregnancy. One month later, with an ultrasound and detection of fetal heartbeat, clinical pregnancy will be confirmed.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Having 2 to 3 follicles of suitable size, open tubes, acceptable sperm test for intrauterine insemination
Exclusion criteria:
Age over 42 years, bilateral tubular obstruction, couples with sperm concentration less than ten million spermatozoa per millilitre
-
Intervention groups
-
Control group:
30 patients, a catheter without mandrel, produced by Salamatyar Hakim engineering Company, will be used for intrauterine insemination of sperm.
Intervention group:
30 patients, a catheter with mandrel, produced by Salamatyar Hakim engineering Company, will be used for intrauterine insemination of sperm.
-
Main outcome variables
-
Primary outcomes:
Problem with catheter insertion, Need to Tenaculum, Need for cervical dilatation
Secondary outcomes:
Chemical pregnancy rate, Clinical pregnancy rate